For the past few decades, alpha-1 antitrypsin deficiency (AATD) treatment has been mostly limited to enzyme therapy. While this type of therapy is able to treat symptoms of emphysema and COPD and may even be disease modifying, there is hope that advancements in replacement therapy will improve treatments for pulmonary diseases related to AATD in next … Continue reading Emerging Treatment Options for Alpha-1 Antitrypsin Deficiency (AATD)